All News

Two-time cancer survivor offers the perspective of time and experience to fellow survivors.

Roy Herbst, M.D., Ph.D., spoke with CURE about the future of Keytruda, and immunotherapy in general, to treat lung cancer.

Imbruvica was granted an accelerated FDA approval to treat some patients with marginal zone lymphoma (MZL).

Genetics can help determine a patient's risk of developing a brain tumor, as well as what treatments may work.

A recent study found that there has been a sharp decrease in the percentage of men who are being treated for prostate cancer.

A patient with metastatic breast cancer offers nine steps to getting away from fear.

While the stereotypical cancer caregiver is someone who is older, The Caregiver Space realizes that this group is diverse in age and profession. The online resource center seeks to support them all.

Patients, survivors, advocacy groups and politicians share their views on the upcoming repeal of the Affordable Care Act.

The results of a recent study showed that a wait-and-watch approach may be appropriate for patients with rectal cancer.

Attitude. Belief. Courage.

Health professionals have always touted the benefits of exercise, but what role, if any, does exercise play in helping fighting post-cancer fatigue?

There is a need to find biomarkers that may help predict recurrence in HPV+ oropharyngeal cancer, says Matthew E. Spector, M.D.

The FDA recently issued a warning that a type of medicine used to treat Type 2 diabetes may increase a person's risk for developing bladder cancer.

An expanded access program (EAP) was just opened up for ceratain patients with ovarian cancer to receive niraparib.

Imbruvica (ibrutinib) improved survival for patients with small lymphocytic lymphoma (SLL) and chronic lymphocytic leukemia (CLL), according to study results that were recently presented.

CURE spoke with Maria Ignez Braghiroli, M.D. about the need for individualized treatment for patients with NRAS-mutant metastatic colorectal cancer.

On January 19, we'll be co-hosting a tweet chat with Oncology Nursing News and Jen Sotham about the phrases and language used by the cancer community. Join us at 9 p.m. EST with the hashtag #CureConnect

A recent study examined the relationship between polycystic ovarian syndrome, long or irregular periods and ovarian cancer risk.

After a bout with cancer, many things change. Quite a few of those things are changes that can never be changed back to the way it used to be. So, how does one go about learning acceptance?

Kim Johnson discusses making better choices in the face of the unknown after cancer.

A large study at the University of Rochester Medical Center’s Wilmot Cancer Institute sought out to get to the root of the causes of cancer-related cognitive impairment and who may be at risk.

A team of researchers at the University of Buffalo investigated the role that patients' stress and anxiety plays in deciding on treatment.

The World Health Organization (WHO) reclassified some types of brain cancers, giving a clearer outline on how to treat them.

The FDA recently warned consumers about PNC-27, a non-approved "treatment" for cancer.

Brian J. Czerniecki, M.D., Ph.D., discusses a promising vaccine for certain patients with breast cancer.

While there is a difference between cancer and mundane medical crises, the mundane counts. Try to be holistic. Survive flu season as well as cancer. Practice wellness.

Breast cancer and melanoma survivor who is also a clutter-clearing author shares her tips for cancer and other papers.

From publications to one-on-one interactions, SPOHNC offers caregivers, patients and survivors of oral, head and neck cancer support they need to navigate their diagnosis.